• Home
  • Search Results

Search Results

Older Adult (65+)
2144 studies match your search
Open

Pilot study to assess and improve quality of 2D and 3D non-invasive diagnostic ultrasound imaging

Dear Colleagues and Students, We are conducting a study to understand how the quality of 2D and 3D ultrasound imaging of different organs (lungs, liver etc) can be improved. You may qualify if you 21 years and older Have no known lung and heart diseases Are not pregnant Participation involves A single laboratory visit Weighing and height measurement Being scanned with non-invasive ultrasound THERE IS NO DIRECT BENEFIT FROM PARTICIPATING IN THIS STUDY, BUT THE DATA WE COLLECT MYA HELP IMPROVE ULTRASOUND IMAGING FOR PATIENTS IN THE FUTURE For information please contact Oleksii Ostras by phone at 919-579-8328 or by email at oleksii@email.unc.edu. Pinton Laboratory, Joint Department of Biomedical Engineering (9212 Mary Ellen Jones Biulding)

Age & Gender
  • 21 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
Open

Phase 1 pilot study with dose expansion of chemotherapy in combination with CD40 agonist and Flt3 ligand in metastatic triple negative breast cancer

Have you been diagnosed with metastatic triple negative breast cancer and have had progression of your cancer during or following your most recent cancer treatment? If so, you may be eligible for a study looking at the combination of two investigational drugs with doxil for patients with metastatic triple negative breast cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Open

Intermediate Risk Prostate Cancer Trial

Do you have intermediate risk prostate cancer and don't want to undergo surgery? You may be able to participate in a research study comparing therapy based on genetic testing.

Age & Gender
  • 18 years ~ 99 years
  • Male
Study Interest
  • Cancer (Prostate)
Open

An avocado intervention to increase the nutrient quality of human milk in support of infant cognitive development.

Are you or do you plan to exclusively breastfeed your baby? We are conducting a research study to determine if eating avocados changes the nutrients in your milk and if so, how that affects your baby's recognition memory and overall development. Avocados will be provided!

Age & Gender
  • 3 months ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Eating, Nutrition, and Metabolism
Not currently enrolling

Developing a multicultural viewpoint framework for the providers to comprehend the caregiver's unique grief experiences.

We want to help people from different cultures who live in America. Sometimes they have a hard time getting the right care because they are different from most Americans. We want to learn their understanding of their grief and the cultural factors that influence their grieving process. We want to talk to them and listen to their stories. This way, we can help them trust the doctors and nurses caring for them. We can also help them find more support online. We think this will make them healthier and happier. We also want to show others that having different feelings and beliefs is okay. We hope that by doing this study, we can help the therapists develop a deeper understanding of the grieving experiences and provide culturally appropriate care to their patients.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Healthy Volunteer or General Population
  • Mental and Emotional Health
  • and 5 more
Visit Location
100% Remote (online, phone, text)
Not currently enrolling

EoE Study with Dupixent

The purpose of this study is to learn whether Dupixent (dupilumab) can help with the esophagus's function in adults with eosinophilic esophagitis.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Allergy
  • Chronic Conditions
  • Stomach, Digestion and Gut Health
  • Rare Diseases
Open

Phase 2 Relapsed or Refractory Multiple Myeloma Study

Have you been diagnosed with relapsed or refractory multiple myeloma? If so you may be able to take part in a research study looking at the safety and efficacy of giving BMS-986393 to patients with multiple myeloma.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Multiple Myeloma)
Open

ONC-392 plus Lu 177 vipivotide in ARTA resistant mCRPC

Have you been diagnosed with Metastatic Castration-Resistant Prostate Cancer (mCRPC)? If so, you may be able to take part in a research study investigating if the study drug together with standard of care drug are safe and well tolerated, and whether two drugs are effective in treating prostate cancer, in comparison with standard of care alone.

Age & Gender
  • 18 years ~ 99 years
  • Male
Study Interest
  • Cancer (Prostate)
  • Men's Health

Autologous Anti-HER2 Chimeric Antigen Receptor Monocytes (CT-0525) in Participants with HER2 Over Expressing Solid Tumors

The purpose of this study is to learn about the effects of a research investigational product, CT-0525, and to see if CT-0525 is safe for participants with advanced cancer. This study is the first time that CT-0525 will be given to humans. CT-0525 is a special kind of product that is made of blood cells taken from your own body. Once collected, these blood cells will be altered and infused back into your body.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Phase 1 Trials (all cancers))
Not currently enrolling

IgA Nephropathy Microbiome Study

The purpose of this study is to compare diet (record of the foods you eat), gut microbiome (stool sample), and cells (blood sample) in adults with IgA Nephropathy (IgAN) and compare with adults with focal segmental glomerulosclerosis (FSGS) and adults with no history of medical problems. The information we learn by doing this study may help us understand how we might be able to target the microbiome to better understand the disease process and potentially help us develop new therapies in the future.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
  • Kidneys and Liver
  • Microbiome
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research